Table 3.

Clinical and biochemical findings observed during the follow-up perioda

Symptoms No. of Patients
aiPTH, intact parathyroid hormone; dRTA, distal renal tubular acidosis.
Hypomagnesemia 33/33 (100%)
Hypercalciuria 33/33 (100%)
Nephrocalcinosis 33/33 (100%)
Polyuria/polydipsia 28/31 (90%)
Increased serum iPTH levels 22/25 (88%)
Incomplete dRTA 17/20 (85%)
Hypocitraturia 12/15 (80%)
Urinary tract infection 22/32 (69%)
Hyperuricemia 18/28 (64%)
Muscular tetany 10/30 (33%)
Nephrolithiasis 10/31 (32%)
Ocular pathologic conditions 8/31 (26%)
Cerebral convulsions 5/30 (17%)
Hearing impairment 0/33 (0%)